Update on chikungunya fever
The Centre for Health Protection (CHP) of the Department of Health announced that, as of 5pm today (January 27), no new cases of chikungunya fever (CF) had been recorded.
Latest surveillance data
---------------------------
Hong Kong has recorded a total of 82 confirmed CF cases last year. Among them, 11 were local cases, and the rest were imported cases.
Since the beginning of 2025, and as of December 10, 2025, a total of 502 264 CF cases and 186 CF-related deaths have been reported in over 40 countries/territories. Cases have been reported in the Americas, Africa, Asia, and Europe. Although the northern hemisphere has entered the winter season, temperatures in subtropical and some temperate regions remain elevated due to climate change, creating favourable conditions for mosquito breeding. In addition, CF outbreaks continue to occur in many countries worldwide. The risk of imported cases persists. Members of the public should check the situation of the destinations before travelling abroad, especially when travelling to Southeast Asian countries.
Continuously strengthening prevention and control
---------------------------------------------------------
Given that some local cases of CF have visited the Tsing Yi Nature Trails or the surrounding area in November last year, the trails are currently closed until further notice. Relevant government departments (including the Food and Environmental Hygiene Department (FEHD), Kwai Tsing District Office, Lands Department, Drainage Services Department, and Civil Engineering and Development Department) have been continuously conducting comprehensive mosquito control and environmental remediation work along the trails. Since the confirmation on December 10, 2025, of a case involving a person who had visited the Tsing Yi Nature Trails on November 30, 2025, no further local cases have been recorded to date.
The FEHD and relevant departments have comprehensively enhanced the mosquito control operations in Hong Kong since July last year, and this has continued. Among these, the FEHD has conducted vector investigations and targeted mosquito control operations against the imported and local cases. In light of the local cases, the FEHD has immediately conducted follow-up actions, including:
- carrying out intensive fogging in scrubby areas within a 250-metre radius of the relevant locations to kill adult mosquitoes;
- carrying out inspections of the locations, removing stagnant water, applying insecticides and disposing of abandoned water containers every week with a view to preventing mosquito breeding; and
- enhancing public education efforts through organising health talks, setting up mobile education stations, and distributing publicity leaflets.
The abovementioned measures will be continued. Furthermore, the Government will further enhance the mosquito control efforts in addition to the existing measures.
Preventive measures to be taken by the public
----------------------------------------------------
Members of the public should use DEET-containing insect repellents or other effective active ingredients properly to prevent mosquito bites, but the following precautions should be taken when using them:
- read the label instructions carefully first;
- apply right before entering an area with a risk of mosquito bites;
- apply on exposed skin and clothing;
- use DEET of up to 30 per cent for pregnant women and up to 10 per cent for children (for children who travel to countries or areas where mosquito-borne diseases are endemic or epidemic and where exposure is likely, those aged 2 months or above can use DEET-containing insect repellents with a DEET concentration of up to 30 per cent);
- apply sunscreen first, then insect repellent;
- reapply only when needed and follow the instructions; and
- in addition to DEET, there are other insect repellents available on the market containing different active ingredients, such as IR3535 and picaridin. When using any insect repellent, the public should follow the usage instructions and precautions on the product label.
The FEHD also appeals to members of the public to continue to stay alert and work together to carry out mosquito prevention and control measures early, including inspecting their homes and surroundings to remove potential breeding grounds, changing water in vases and scrubbing their inner surfaces, removing water in saucers under potted plants at least once a week, and properly disposing of containers such as empty cans and lunch boxes. The FEHD also advises members of the public and property management agencies to keep drains free of blockage and level all defective ground surfaces to prevent the accumulation of water. They should also scrub all drains and surface sewers with an alkaline detergent at least once a week to remove any mosquito eggs.
The public should call 1823 in case of mosquito problems, and may visit the following pages for more information: the CF page of the CHP and the Travel Health Service, the latest Travel Health News, tips for using insect repellents, and the CHP Facebook Page, Instagram Account and YouTube Channel, and also the Mosquito Prevention and Control dedicated page of the FEHD.
Source: AI-created image
15th China Chest Pain Centers Congress convenes in Hong Kong: Chest pain treatment standards go global, joining hands to elevate care quality
The following is issued on behalf of the Hospital Authority:
The Hospital Authority (HA) announced today (April 3) that the 15th China Chest Pain Centers Congress (CCPCC 2026) is being held at the Hong Kong Convention and Exhibition Centre over two days (April 3 and 4), bringing together about 3 000 medical professionals from Hong Kong, Chinese Mainland, the Belt and Road countries and regions and around the world. This marks the first time the Congress is being held in Hong Kong, with the city serving as an important bridge in bringing national chest pain treatment standards onto the international stage, representing a significant milestone for the Congress.
This year's Congress features 16 professional forums and over 200 specialised lectures, covering cutting-edge healthcare innovations, AI-assisted clinical decision-making, intelligent emergency response systems, and international accreditation standards. The event aims to establish a platform for academic exchange, innovation, and collaboration in chest pain centre development and cardiovascular medicine, facilitating the sharing of new medical knowledge and experience, and collectively exploring the latest directions in contemporary cardiovascular healthcare services.
The Congress is jointly organised by the HA, the National Clinical Research Center for Interventional Medicine, the Guangdong Chest Pain Centers Association, and the Chinese Cardiovascular Association. The opening ceremony was held this morning, officiated by the Secretary for Health, Professor Lo Chung-mau; Second-Level Inspector of the Health Commission of Guangdong Province, Mr Wu Jingzen; Chairperson of the Organising Committee (Chinese Mainland), Academician Professor Ge Junbo; Chairperson of the Organising Committee (Chinese Mainland), Professor Yong Huo; Legislative Council Member for the Medical and Health Services functional constituency, Dr Hon David Lam; the Dean of the Faculty of Medicine, the Chinese University of Hong Kong, Professor Philip Chiu, the HA Chairman, Mr Henry Fan; and the HA Chief Executive and the Chairperson of the Organising Committee (Hong Kong), Dr Libby Lee.
Mr Fan stated that CCPCC 2026 being held in Hong Kong for the first time fully demonstrates Hong Kong's unique position as an international hub for medical exchange.
Mr Fan said "Countries and regions around the world are currently facing the severe challenge of a growing number of acute cardiac cases. Strengthening medical exchange and collaboration, and driving medical innovation, are therefore of paramount importance. I believe this Congress will bring fruitful academic achievements to all attendees and inject new momentum into the global development of cardiovascular medicine, ultimately benefiting more patients."
Dr Lee, in her opening address, stated that the HA has always been committed to enhancing the quality of acute cardiac services in public hospitals and actively collaborates closely with Chinese Mainland counterparts to promote the integration of high-quality medical services.
Dr Lee said "Hong Kong's healthcare system is renowned for its efficiency, professionalism, and excellence. The Chest Pain Centre at Queen Mary Hospital has achieved accreditation under the National Chest Pain Centre Construction Standards, and the Chest Pain Centre at Prince of Wales Hospital will also undergo accreditation in due course. Establishing chest pain centres have yielded significant results in improving chest pain treatment processes and enhancing service efficiency, benefiting patients and fully demonstrating Hong Kong's deep commitment to standardised care, multidisciplinary coordination, and timely intervention. Hong Kong's experience can also serve as an important reference for global chest pain centre development. I look forward to collaborating with the Chinese Mainland and international medical communities through this Congress to jointly promote innovation and sustainable development in cardiovascular medicine."
During the CCPCC 2026, the "Chest Pain Center Construction and Accreditation Standards (International Version)" has been officially issued. This standard provides a framework for healthcare institutions worldwide to establish high-quality chest pain centres, which aims to standardise treatment protocols, improve clinical outcomes, enhance clinical prognosis, promote the standardised development of chest pain centres internationally, and ultimately raise the overall level of global chest pain treatment.
The 15th China Chest Pain Centers Congress is being held in Hong Kong on April 3 and 4, bringing together about 3 000 medical professionals from Hong Kong, Chinese Mainland, the Belt and Road countries and regions and around the world. Source: HKSAR Government Press Releases
The 15th China Chest Pain Centers Congress is being held in Hong Kong on April 3 and 4. The opening ceremony was held this morning (April 3), officiated by the Secretary for Health, Professor Lo Chung-mau (fourth left); Second-Level Inspector of the Health Commission of Guangdong Province, Mr Wu Jingzen (third left); Chairperson of the Organising Committee (Chinese Mainland), Academician Professor Ge Junbo (second left); Chairperson of the Organising Committee (Chinese Mainland), Professor Yong Huo (first left); Legislative Council Member for the Medical and Health Services functional constituency, Dr Hon David Lam (fourth right); the Dean of the Faculty of Medicine of the Chinese University of Hong Kong, Professor Philip Chiu (first right); the HA Chairman, Mr Henry Fan (third right) and the HA Chief Executive and the Chairperson of the Organising Committee (Hong Kong), Dr Libby Lee (second right). Source: HKSAR Government Press Releases
